Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 1995. Start Trial.
Date Value
September 30, 2025 72.18M
September 30, 2024 49.74M
September 30, 2023 17.49M
September 30, 2022 -466.05M
September 30, 2021 149.86M
September 30, 2020 37.87M
September 30, 2019 90.90M
September 30, 2018 73.96M
September 30, 2017 96.22M
September 30, 2016 39.55M
September 30, 2015 43.73M
September 30, 2014 53.78M
September 30, 2013 54.39M
September 30, 2012 36.04M
September 30, 2011 87.65M
September 30, 2010 27.87M
Date Value
September 30, 2009 -56.49M
September 30, 2008 13.66M
September 30, 2007 72.87M
September 30, 2006 65.19M
September 30, 2005 31.11M
September 30, 2004 8.855M
September 30, 2003 -48.33M
September 30, 2002 -55.66M
September 30, 2001 20.68M
September 30, 2000 -13.18M
September 30, 1999 5.472M
September 30, 1998 0.045M
September 30, 1997 -1.991M
September 30, 1996 -2.148M
September 30, 1995 -7.221M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.559B
Bio-Rad Laboratories, Inc. 532.20M
Bruker Corp. 134.10M
Danaher Corp. 6.416B
Harvard Bioscience, Inc. 6.729M